Gerresheimer AG

    Jurisdiction
    Germany
    LEI
    5299006GD4UWSYZOKC28
    ISIN
    DE000A0LD6E6 (GXI.DE)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    InsiderPie Expert Score
    53 / 100
    Even with peer group:
    53 / 100
    Fair value (Benjamin Graham formula)
    €72.79 137.4% undervalued
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. Read full profile

    Fundamentals

    Net revenue
    €2.17B
    Gross margin
    29.3%
    EBIT
    €216.25M
    EBIT margin
    10.0%
    Net income
    €113.74M
    Net margin
    5.2%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.51B +15.6% €100.00M -12.1%
    €2.67B +6.3% €133.94M +33.9%
    €2.80B +4.7% €160.30M +19.7%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    €0.04
    Ex date
    Payment date
    Dividend payout ratio
    38.0%

    Analyst ratings

    8 analysts rated this company in the past 90 days. The average target price is €68.13, this is a change of +122.2% compared to the current price.

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Earnings Calls

    Latest earnings call: April 11, 2025 (Q1 2025)

    Add to watchlist

    Notifications